Prostate cancer: polygenic risk scores have not shown clinical benefit
BMJ
.
2025 Jun 10:389:r1179.
doi: 10.1136/bmj.r1179.
Authors
Anneke Lucassen
1
,
Margaret McCartney
2
,
Richard Sullivan
3
Affiliations
1
Centre for Human Genetics, University of Oxford, Oxford, UK.
2
University of St Andrews, St Andrews, UK.
3
Institute of Cancer Policy, King's College London, London, UK.
PMID:
40494614
DOI:
10.1136/bmj.r1179
No abstract available
Publication types
Letter